AU2002360185A1 - Homologous recombination vector, preparations and uses - Google Patents

Homologous recombination vector, preparations and uses

Info

Publication number
AU2002360185A1
AU2002360185A1 AU2002360185A AU2002360185A AU2002360185A1 AU 2002360185 A1 AU2002360185 A1 AU 2002360185A1 AU 2002360185 A AU2002360185 A AU 2002360185A AU 2002360185 A AU2002360185 A AU 2002360185A AU 2002360185 A1 AU2002360185 A1 AU 2002360185A1
Authority
AU
Australia
Prior art keywords
preparations
homologous recombination
recombination vector
vector
homologous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002360185A
Other languages
English (en)
Inventor
Sophie Chappuis-Flament
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2002360185A1 publication Critical patent/AU2002360185A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2002360185A 2001-11-23 2002-11-22 Homologous recombination vector, preparations and uses Abandoned AU2002360185A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR01/15185 2001-11-23
FR0115185A FR2832726A1 (fr) 2001-11-23 2001-11-23 Vecteur de recombinaison homologue, preparations et utilisations
PCT/FR2002/004011 WO2003044203A2 (fr) 2001-11-23 2002-11-22 Vecteur de recombinaison homologue, preparations et utilisations

Publications (1)

Publication Number Publication Date
AU2002360185A1 true AU2002360185A1 (en) 2003-06-10

Family

ID=8869724

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002360185A Abandoned AU2002360185A1 (en) 2001-11-23 2002-11-22 Homologous recombination vector, preparations and uses

Country Status (3)

Country Link
AU (1) AU2002360185A1 (fr)
FR (1) FR2832726A1 (fr)
WO (1) WO2003044203A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101422607B (zh) * 2008-10-08 2011-11-16 中国农业科学院哈尔滨兽医研究所 小反刍兽疫重组山羊痘病毒活载体疫苗
WO2012165270A1 (fr) * 2011-05-27 2012-12-06 公立大学法人横浜市立大学 Vecteur de ciblage génique, son procédé de fabrication, et son procédé d'utilisation
US9303272B2 (en) 2011-12-13 2016-04-05 Public University Corporation Yokohama City University Gene targeting vector, and method for using same
RU2678756C1 (ru) * 2017-08-25 2019-01-31 Селл энд Джин Терапи Лтд Генотерапевтический ДНК-вектор VTvaf17, способ его получения, штамм Escherichia coli SCS110-AF, способ его получения, штамм Escherichia coli SCS110-AF/VTvaf17, несущий генотерапевтический ДНК-вектор VTvaf17, способ его получения
RU2720521C1 (ru) * 2018-11-29 2020-04-30 Селл энд Джин Терапи Лтд Генотерапевтический ДНК-вектор на основе генотерапевтического ДНК-вектора VTvaf17, несущий целевой ген, выбранный из группы генов BMP-2, BMP-7, LMP-1, NELL-1 для повышения уровня экспрессии этих целевых генов, способ его получения и применения, штамм Escherichia coli SCS110-AF/VTvaf17-BMP-2, или Escherichia coli SCS110-AF/VTvaf17-BMP-7, или Escherichia coli SCS110-AF/VTvaf17-LMP-1, или Escherichia coli SCS110-AF/VTvaf17-NELL-1, несущий генотерапевтический ДНК-вектор, способ его получения, способ производства в промышленных масштабах генотерапевтического ДНК-вектора
RU2720519C1 (ru) * 2018-11-29 2020-04-30 Селл энд Джин Терапи Лтд Генотерапевтический ДНК-вектор на основе генотерапевтического ДНК-вектора VTvaf17, несущий целевой ген, выбранный из группы генов IFNB1, IFNA14, IFNA2, IL12A, IL12B для повышения уровня экспрессии этих целевых генов, способ его получения и применения, штамм Escherichia coli SCS110-AF/VTvaf17-IFNB1, или Escherichia coli SCS110-AF/VTvaf17-IFNA14, или Escherichia coli SCS110-AF/VTvaf17-IFNA2, или Escherichia coli SCS110-AF/VTvaf17-IL12A, или Escherichia coli SCS110-AF/VTvaf17-IL12B, несущий генотерапевтический ДНК-вектор, способ его получения, способ производства в промышленных масштабах генотерапевтического ДНК-вектора
RU2720376C1 (ru) * 2018-11-29 2020-04-29 Селл энд Джин Терапи Лтд Генотерапевтический ДНК-вектор на основе генотерапевтического ДНК-вектора VTvaf17, несущий целевой ген, выбранный из группы генов IL11, LIF, DICER, HOXA10, WT1, для повышения уровня экспрессии этих целевых генов, способ его получения и применения, штамм Escherichia coli SCS110-AF/VTvaf17-IL11, или Escherichia coli SCS110-AF/VTvaf17-LIF, или Escherichia coli SCS110-AF/VTvaf17-DICER, или Escherichia coli SCS110-AF/VTvaf17-HOXA10, или Escherichia coli SCS110-AF/VTvaf17-WT1, несущий генотерапевтический ДНК-вектор, способ его получения, способ производства в промышленных масштабах генотерапевтического ДНК-вектора
RU2715314C1 (ru) * 2019-01-25 2020-02-26 Селл энд Джин Терапи Лтд Генотерапевтический ДНК-вектор VTvaf17-Act1-Cas9 на основе генотерапевтического ДНК-вектора VTvaf17, несущий целевой ген Cas9, для гетерологичной экспрессии этого целевого гена в клетках растений при геномном редактировании растений, способ получения и применения генотерапевтического ДНК-вектора, штамм Escherichia coli SCS110-AF/VTvaf17-Act1-Cas9, несущий генотерапевтический ДНК-вектор, способ его получения, способ производства в промышленных масштабах генотерапевтического ДНК-вектора
WO2023183528A2 (fr) * 2022-03-24 2023-09-28 Memorial Sloan-Kettering Cancer Center Compositions comprenant ifne et leurs utilisations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0907726A4 (fr) * 1996-06-26 2001-11-07 Baylor College Medicine Rearrangement chromosomique par insertion de deux substrats de recombinaison
EP0939120A1 (fr) * 1998-02-27 1999-09-01 Gesellschaft für biotechnologische Forschung mbH (GBF) Méthode pour l'échange répétifif, dépourvu de marqueurs, de cassettes d'expression d'ADN dans le génome de cellules ou de parties de cellules

Also Published As

Publication number Publication date
WO2003044203A2 (fr) 2003-05-30
FR2832726A1 (fr) 2003-05-30
WO2003044203A3 (fr) 2004-02-12

Similar Documents

Publication Publication Date Title
AUPR464601A0 (en) Shapes vector
EP1209986B8 (fr) Compositions contenant du metal, preparations et utilisations
AU2001294192A1 (en) Solid preparations
AU2002236159A1 (en) Immunogenic complex
AUPR419701A0 (en) An improved backpack
IL159504A0 (en) Pesticide preparations comprising copolymers
AU2001232054A1 (en) Vector
AU2001242479A1 (en) Proliposomal encapsulated preparations
AU2002360185A1 (en) Homologous recombination vector, preparations and uses
AUPR458601A0 (en) Parcel networks
AU2002356616A1 (en) 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide
AU3883800A (en) Hob-bp2h compositions, methods and uses thereof
AU2002358142A1 (en) Low-dust solid fuel preparations
AU2001288102A1 (en) Solid preparations
AU2002360417A1 (en) Genetically stable expression vector
AU2001282521A1 (en) OCT preparations
AU2001272427A1 (en) Solid preparations
AU4672401A (en) Vectors
AU2002357506A1 (en) Acid-containing preparations
AU2002213398A1 (en) Expression vectors and uses thereof
AU2002217863A1 (en) Homing peptide multimers, their preparation and uses
AU2001233891A1 (en) Diphenyl compounds, formulations and uses thereof
AU4835401A (en) Pro-liposome encapsulated preparations
AU2002240285A1 (en) Multipurpose garment
AU2002361263A1 (en) Pants-covering and shoe-covering garments

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase